3rd International Precision Medicine Convention

Register Now Contact Us

3rd International Precision Medicine Convention

Dec.1-Dec.2

Beijing, China

3rd International Precision Medicine Convention

1st Dec –2nd Dec, Beijing China

From biobank construction to genomics optimization, renovating the whole cycle of prevention, diagnosis and treatment for cancer and chronic diseases
  • Introduction
  • About Attendees
  • Event Highlights
  • As the dramatically decreasing of gene sequencing cost and the increasing of gene data, the application of Precision Medicine is not just in diagnosis and treatment but also in risk prediction for disease. The application of Precision Medicine is very extensive nowadays which covers from mature NIPT, tumor companion diagnosis, use guidance for targeted drug and rare genetic diseases screening, to early screening for cancer, accurate health management, and finally make the "4P medical model" (Preventive, Predictive, Individualized and Participatory) come true!

    The in-depth development of Precision Medicine and the application of medical big data strongly is prompting the growth of Gene Sequencing market. P4 China 2018 (3rd International Precision Medicine Convention) will be divided into 5 sub-forum to explore the following topics: The establishment of life omics technology, large cohort, biobank, precision medicine big data platform; The application transformation of personalized diagnosis and treatment decisions, and the precision disease prevention and treatment. P4 China 2018 will discuss step by step the whole process of the frontier application practice of Precision Medicine.

  • Who should attend?

    Medical institutions: Laboratory Medicine, Pathology, Pharmacology, Clinicals

    Medical and Life Science Research Institute

    CDC

    Medical Examination Center, Health Management Center

    ICLs

    Gene Detection, Gene Sequencing Company

    Pharmaceutical Companies, CRO engaged in the development of biomarkers

  • 2018 P4 Point

    Discover the periodical result of the 1st Precise Medicine Plan Research:The breakthrough and progress of clinical molecular typing and mapping of polymorphic diseasesLarge cohort study progressThe research and progress of biomarkers and targets for personalized therapy and IO drugs

    Share the breaking technology and trend of international and domestic precision medicine

    Explore the business module and strategy of gene testing in clinical and consuming diagnosis

    Follow-up the frontier technology and application of accurate diagnosis, personalized medicine and companion diagnosis for tumor

    Discuss the construction and leading practice of biobank and database

    Explore the application of cloud computing and artificial intelligence in gene sequencing big data analysis and interpretation

  • Main Forum
  • Biobank and Biorepository Forum
  • Molecular Early Screening and Diagnostics Forum
  • Personalized Cancer Medicine & Companion Diagnostics Forum
  • Chronic Disease Gene Detection Forum
  • Precision Medicine Technology Forum
  • Sub-forum highlights:

    Following up the latest progress of the implementation of China's precision medical plan

    The case sharing of the translational medicine from international precision medicine technology

    Learning the strategic layout of precision medicine industry from academia, companies, and capitals

    Breaking through the blue sea market and learn business models for clinical and consumer use from leading players

    More
  • Sub-forum highlights:

    The results of big data analysis and database construction of domestic large-scale cohort research

    The standardization construction of biobank and information platform

    Quality control and specifications for sample processing under gene sequencing

    Learning how to translate biobanks and genomics research into clinical practice and accelerate application

    More
  • Sub-forum highlights:

    Clinical application of frontier technology (single-cell sequencing, NGS, biochip) for cancer and genetic diseases

    Development and translation from innovative liquid biopsy technology

    Exploration for new biomarkers in early screening and diagnosis in cancer

    Analysis and interpretation of precision medicine under gene testing

    More
  • Sub-forum highlights:

    Exploring the precise application of NGS panel in personalized cancer medicine

    Tracking precision diagnosis and verification incancer immunotherapy

    Discovery of new biomarkers in personalized medicine, prognosis and recurrence monitoring

    Best practices of frontier diagnosis and treatment systems (artificial intelligence, data mining and integration, etc.) inpersonalized treatment research

    More
  • Sub-forum highlights:

    Discovery of new biomarkers in early screening, diagnosis and personalized medicine for chronic diseases

    Clinical application of chronic disease gene detection

    Precise health management of chronic diseases under bioinformatics and big data

    More
  • Sub-forum highlights:

    Mastering the cutting-edge technology of sample preparation and nucleic acid extraction

    Breakthrough in liquid biopsy technology for tumors and other diseases

    Big data discovery and translation for clinical and consumer gene sequencing

    More

Key Words

Dec.1 AM

Main Forum

Policies and Regulations, International Frontier Translational Medicine, Strategic Layout
Dec.1 - Dec.2

Biobank and Biorepository Forum

Biobank, Biosample Preparation, Bioinformatics Database
Dec.1 - Dec.2

Molecular Early Screening and Diagnostics Forum

Liquid Biopsy, Biomarkers, Early Screening and Diagnosis
Dec.1 - Dec.2

Personalized Cancer Medicine & Companion Diagnostics Forum

Personalized Medicine Panel, Precise Immunotherapy, Biomarkers
Dec.1

Precision Medicine Technology Forum

NGS Technology, Single Cell Sequencing Technology, New PCR Technology
Dec.2

Chronic Disease Gene Detection Forum

Chronic Disease Detection Technology, Clinical Translation and Application, Precise Health Management

Premium Speakers

C. Thomas Caskey

Professor, Molecular and Human Genetics Baylor College of Medicine, Member of: National Academy of Sciences

Daniel Catchpoole

Indo-Pacific Rim Director of ISBER, Head of Tumour Bank, The Children's Hospital at Westmead

Harry Yang

Co-chairman of Committee of Precision Medicine & Companion Diagnostics in China Society of Biotechnology

Lunxiu Qin

Lunxiu Qin, Director of Surgery, Institute of cancer metastasis, Huashan Hospital

Jingmin Zhao

Jingmin Zhao, Director of pathology, the 302 Military Hospital of China.

Jinfei Cheng

Director of the Department of Oncology, Nanjing First Hospital

Yanfang Jiang

Director of the Gene Diagnosis Center, The First Bethune hospital of Jilin University

Shunchang Jiao

Director of Medical Oncology, The General Hospital of the People's Liberation Army

Yuping Liu

Director of Health Management Center of The People's Hospital of Sichuan Province

Jinpu Yu

Direct of Molecular Diagnostic Center, Tianjin Medical University Cancer Institute & Hospital

Jinkui Yang

Director of the Department of Endocrinology, Beijing Tongren Hospital

Qiang Zeng

Director of Institutes of Health, Chinese PLA General Hospital

Tao Dai

Vice Director of China National Health Development Research Center

Ruihua Xu

President of Sun Yat-sen University Cancer Center

Xiaochen Bo

Researcher, Doctoral Supervisor, Director of Science and Technology Department, Academy of Military Science

Check More Speakers

Premium Speakers

  • C. Thomas Caskey

    Professor, Molecular and Human Genetics Baylor College of Medicine, Member of: National Academy of Sciences

  • Daniel Catchpoole

    Indo-Pacific Rim Director of ISBER, Head of Tumour Bank, The Children's Hospital at Westmead

  • Harry Yang

    Co-chairman of Committee of Precision Medicine & Companion Diagnostics in China Society of Biotechnology

  • Lunxiu Qin

    Lunxiu Qin, Director of Surgery, Institute of cancer metastasis, Huashan Hospital

  • Jingmin Zhao

    Jingmin Zhao, Director of pathology, the 302 Military Hospital of China.

  • Jinfei Cheng

    Director of the Department of Oncology, Nanjing First Hospital

  • Yanfang Jiang

    Director of the Gene Diagnosis Center, The First Bethune hospital of Jilin University

  • Shunchang Jiao

    Director of Medical Oncology, The General Hospital of the People's Liberation Army

  • Yuping Liu

    Director of Health Management Center of The People's Hospital of Sichuan Province

  • Jinpu Yu

    Direct of Molecular Diagnostic Center, Tianjin Medical University Cancer Institute & Hospital

  • Jinkui Yang

    Director of the Department of Endocrinology, Beijing Tongren Hospital

  • Qiang Zeng

    Director of Institutes of Health, Chinese PLA General Hospital

  • Tao Dai

    Vice Director of China National Health Development Research Center

  • Ruihua Xu

    President of Sun Yat-sen University Cancer Center

  • Xiaochen Bo

    Researcher, Doctoral Supervisor, Director of Science and Technology Department, Academy of Military Science

Check More Speakers

Recognition and Affirmation for P4 China

Previous
Testimonials

“The conference was very successful; we can see that the host was very experienced from the well organization.”

- Project Manager,Invitrocue

“The conference is well-organized and has high academic level. It is a high- quality academic event.”

- Director, Department of Pathology and Hepatology Beijing 302 Hospital

“What the speakers present are close to the current industry development, and the overall pace of the meeting is in a good order.”

- BD, QuintilesIMS

“The Conference focused on the hot and difficult issues of presicion medicine, and the seminar communication is also very enlightening. ”

- Assistant Professor, Beijing Institute of Genomics,Chinese Academy of Science

Past Attendees

  • 1000+Professional Attendees

  • 100+International Frontier Leaders and Field Experts

  • 60+Leading Suppliers from Gene Testing Equipments and Services

  • 300+Renowned Hospitals and Research Institutions

Download
Agenda

Sponsor
Package

Register
Now

Contact
Us

Go to
Top